Cerus Corp
$2.53
$0.03 (+1.20%)
$2.50Day Range$2.58
Key Statistics
Market Cap
$503.81M
Shares Outstanding
201.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 31, 1997
Round Lot
100
Locale
US
Trading Data
Day Open
$2.50
Day High
$2.58
Day Low
$2.50
Volume
1.46M
VWAP
$2.53
Prev Close
$2.50
Transactions
--
Acc. Volume
--
About Cerus Corp
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841345 employees1220 CONCORD AVENUE, CONCORD, CA, 94520(925) 288-6000IPO Jan 31, 1997US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001020214
- Composite FIGI
- BBG000HBVZX8
- Share Class FIGI
- BBG001S97DG4
- Ticker Root
- CERS
- SIC Code
- 3841
About Cerus Corp (CERS) Stock
Cerus Corp (CERS) closed the 2026-09-16 session at $2.53, up 1.20% versus the previous close (+0.03). The stock opened at $2.50 and traded between $2.50 and $2.58 during that session. Session trading volume was 1.5M shares. The volume-weighted average price (VWAP) is $2.53.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Cerus Corp has a market capitalization of $503.8 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. CERS is listed on the XNAS exchange. The company employs approximately 345 people. Cerus Corp is headquartered in CONCORD, CA. The recorded listing date is 1997-01-31.
On this page you can find market CERS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.